Skip to menu Skip to content Skip to footer

1999

Journal Article

Vaccines for human papillomavirus-associated anogenital disease and cervical cancer: Practical and theoretical approaches

Street, M. D. and Tindle, R. W. (1999). Vaccines for human papillomavirus-associated anogenital disease and cervical cancer: Practical and theoretical approaches. Expert Opinion in Investigational Drugs, 8 (6), 1-16.

Vaccines for human papillomavirus-associated anogenital disease and cervical cancer: Practical and theoretical approaches

1999

Journal Article

T-Helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16

Azoury-Ziadeh, Rania, Herd, Karen, Fernando, Germain J. P., Frazer, Ian H. and Tindle, Robert W. (1999). T-Helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16. Viral Immunology, 12 (4), 297-312. doi: 10.1089/vim.1999.12.297

T-Helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16

1999

Book Chapter

Cell mediated immunity to papillomaviruses

Frazer, I. H. and Tindle, R. (1999). Cell mediated immunity to papillomaviruses. Current research on papillomaviruses. (pp. 151-164) edited by Charles Lacey. Leeds, England: Leeds University Press.

Cell mediated immunity to papillomaviruses

1999

Book Chapter

Safety and Immunogenicity of HPV16 E7/Algammulin

Frazer, I. H., Tindle, R. W., Fernando, G. J., Malcolm, K. M., Herd, K. A., McFadyen, S. M., Cooper, P. D. and Ward, B. G. (1999). Safety and Immunogenicity of HPV16 E7/Algammulin. Vaccines for Human Papillomavirus Infection and Anogenital Disease. (pp. 91-104) edited by R. W. Tindle. Austin, USA: R.G. Landes Company.

Safety and Immunogenicity of HPV16 E7/Algammulin

1999

Book

Vaccines for Human Papillomavirus Infection and Anogenital Disease

Vaccines for Human Papillomavirus Infection and Anogenital Disease. Edited by Tindle, R. W. Richmond, TX United States: R. G. Landes Company, 1999.

Vaccines for Human Papillomavirus Infection and Anogenital Disease

1998

Journal Article

Split tolerance to a viral antigen expressed in thymic epithelium and keratinocytes

Frazer, Ian H., Fernando, Germain J. P., Fowler, Nina, Leggatt, Graham R., Lambert, Paul F., Liem, Amy, Malcolm, Karen and Tindle, Robert W. (1998). Split tolerance to a viral antigen expressed in thymic epithelium and keratinocytes. European Journal of Immunology, 28 (9), 2791-2800. doi: 10.1002/(SICI)1521-4141(199809)28:093.0.CO;2-B

Split tolerance to a viral antigen expressed in thymic epithelium and keratinocytes

1998

Journal Article

Th2-type CD4(+) cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model

Fernando, Germain J. P., Stewart, Trina J., Tindle, Robert W. and Frazer, Ian H. (1998). Th2-type CD4(+) cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model. Journal of Immunology, 161 (5), 2421-2427.

Th2-type CD4(+) cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model

1998

Journal Article

Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes

Doan, Tracy, Chambers, Melita, Street, Michael, Fernando, Germain J. P., Herd, Karen, Lambert, Paul and Tindle, Robert (1998). Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes. Virology, 244 (2), 352-364. doi: 10.1006/viro.1998.9128

Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes

1998

Journal Article

Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term

Fernando, G. J. P., Stewart, T. J., Tindle, R. W. and Frazer, I. H. (1998). Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term. Scandinavian Journal of Immunology, 47 (5), 459-465. doi: 10.1046/j.1365-3083.1998.00327.x

Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term

1997

Journal Article

Immunomanipulative strategies for the control of human papillomavirus associated cervical disease

Tindle, Robert W. (1997). Immunomanipulative strategies for the control of human papillomavirus associated cervical disease. Immunologic Research, 16 (4), 387-400. doi: 10.1007/BF02786401

Immunomanipulative strategies for the control of human papillomavirus associated cervical disease

1997

Journal Article

Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal

Dunn, Linda A., Evander, Magnus, Tindle, Robert W., Bulloch, Anne Louise, de Kluyver, Rachel L., Fernando, Germain J. P., Lambert, Paul F. and Frazer, Ian H. (1997). Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal. Virology, 235 (1), 94-103. doi: 10.1006/viro.1997.8650

Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal

1997

Journal Article

E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 protein

Herd, K., Fernando, G. J. P., Dunn, L. A., Frazer, I. H., Lambert, P. and Tindle, R. W. (1997). E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 protein. Virology, 231 (1), 155-165. doi: 10.1006/viro.1997.8491

E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 protein

1996

Journal Article

Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein

Zerfass-Thome, Karin, Zwerschke, Werner, Mannhardt, Boris, Tindle, Robert, Botz, Jürgen W. and Jansen-Dürr, Pidder (1996). Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene, 13 (11), 2323-2330.

Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein

1996

Journal Article

Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen

Londono, L. Patricia, Chatfield, Steven, Tindle, Robert W., Herd, Karen, Gao, Xiao-Ming, Frazer, Ian and Dougan, Gordon (1996). Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. Vaccine, 14 (6), 545-552. doi: 10.1016/0264-410X(95)00216-N

Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen

1996

Journal Article

Human papillomavirus vaccines for cervical cancer

Tindle, Robert W (1996). Human papillomavirus vaccines for cervical cancer. Current Opinion in Immunology, 8 (5), 643-650. doi: 10.1016/S0952-7915(96)80080-X

Human papillomavirus vaccines for cervical cancer

1995

Journal Article

Section review: Biologicals & immunologicals: Human papillomavirus infection, genital warts and cervical cancer: Prospects for prophylactic and therapeutic vaccines

Tindle, Robert W. and Frazer, Ian H. (1995). Section review: Biologicals & immunologicals: Human papillomavirus infection, genital warts and cervical cancer: Prospects for prophylactic and therapeutic vaccines. Expert Opinion on Investigational Drugs, 4 (9), 783-797. doi: 10.1517/13543784.4.9.783

Section review: Biologicals & immunologicals: Human papillomavirus infection, genital warts and cervical cancer: Prospects for prophylactic and therapeutic vaccines

1995

Journal Article

Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease

Frazer, I. H., Leippe, D. M., Dunn, L. A., Liem, A., Tindle, R. W., Fernando, G. J. P., Phelps, W. C. and Lambert, P. F. (1995). Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease. Cancer Research, 55 (12), 2635-2639.

Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease

1995

Journal Article

T-helper epitopes of the E7 transforming protein of cervical-cancer associated human papillomavirus type-18 (hpv18)

Fernando, G.J.P., Tindle, R.W and Frazer, I.H. (1995). T-helper epitopes of the E7 transforming protein of cervical-cancer associated human papillomavirus type-18 (hpv18). Virus Research, 36 (1), 1-13. doi: 10.1016/0168-1702(94)00101-H

T-helper epitopes of the E7 transforming protein of cervical-cancer associated human papillomavirus type-18 (hpv18)

1995

Journal Article

A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants

Tindle, R. W., Croft, S., Herd, K., Malcolm, K., Geczy, A. F., Stewart, T. and Fernando, G. J. (1995). A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants. Clinical and Experimental Immunology, 101 (2), 265-271. doi: 10.1111/j.1365-2249.1995.tb08349.x

A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants

1995

Journal Article

Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a production

Fernando, Germain J. P., Stenzel, Deborah J., Tindle, Robert W., Merza, Malik S., Morein, Bror and Frazer, Ian H. (1995). Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a production. Vaccine, 13 (15), 1460-1467. doi: 10.1016/0264-410X(95)00029-Z

Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a production